Literature DB >> 9058872

Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction.

P Geelen1, J Brugada, E Andries, P Brugada.   

Abstract

Two hundred thirty-five patients underwent RF catheter ablation of AV conduction for symptomatic drug refractory AF (84%), atrial flutter (9%), and atrial tachycardia (7%). In the first 100 patients, postablation pacing was not prospectively set at any specific rate and was always < or = 70 beats/min. In the next 135 patients, postablation pacing was prospectively set at 90 beats/min for 1-3 months. Six of the first 100 patients (6%) had VF or sudden death after the RF procedure and none (0%) of the next 135 patients did (P < 0.05). One of the six patients had recurrent VF 4 days after the ablation. Five patients were successfully resuscitated and one patient died. There were no statistically significant differences between patients with and without (aborted) sudden death or between the first 100 and the next 135 patients with respect to age, sex, underlying heart disease, EF, number of RF applications, or left-or right-sided approach of the procedure. VF mostly occurred during episodes of slow ventricular escape rhythms or during slow ventricular pacing. We conclude that malignant ventricular arrhythmias and sudden death are possible complications of RF ablation of the AV function. The mechanism of these complications could have a bradycardia dependent nature and it seems that the occurrence of malignant arrhythmias can be prevented by temporarily pacing the heart at relatively fast rates immediately after ablation.

Entities:  

Mesh:

Year:  1997        PMID: 9058872     DOI: 10.1111/j.1540-8159.1997.tb06179.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  21 in total

1.  Atrial Fibrillation.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-08

2.  Rate control in atrial fibrillation: what approach is best?

Authors:  Brian Olshansky
Journal:  Curr Cardiol Rep       Date:  2004-09       Impact factor: 2.931

3.  [Not Available].

Authors:  S Schickel; J Hluchy; U Jörger; A Langkau; C Linder; G V Sabin
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2000-01

Review 4.  Pathophysiology and clinical implications of cardiac memory.

Authors:  Darwin Jeyaraj; Mahi Ashwath; David S Rosenbaum
Journal:  Pacing Clin Electrophysiol       Date:  2009-12-16       Impact factor: 1.976

5.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

6.  Rate versus rhythm control strategies for AF.

Authors:  Brian Olshansky
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-10

7.  Device-based therapies for atrial fibrillation.

Authors:  Gregory K Bruce; Paul A Friedman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-10

Review 8.  Atrial Fibrillation and Heart Failure.

Authors:  William G Stevenson; Usha B Tedrow; Jens Seiler
Journal:  J Atr Fibrillation       Date:  2008-07-16

9.  Atrioventricular Nodal Catheter Ablation in Atrial Fibrillation Complicating Congestive Heart Failure.

Authors:  Osmar Antonio Centurión; Karina Elizabeth Scavenius; Laura B García; Luis Miño; Judith Torales; Orlando Sequeira
Journal:  J Atr Fibrillation       Date:  2018-06-30

Review 10.  Clinical results with catheter ablation: AV junction, atrial fibrillation and ventricular tachycardia.

Authors:  Jonathan Weinstock; Paul J Wang; Munther K Homoud; Mark S Link; N A Mark Estes
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.